Strategies to Ensure Endpoint Reliability in Rare & Orphan Disease Research

Orphan/rare disease trials present unique challenges—small patient populations, geographically dispersed investigators, and the need for specialized outcome measures are just a few.

At Signant, we leverage more than 25 years of expertise to help you navigate these complexities and ensure reliable, high-quality data. From neurodevelopmental assessments to quality-of-life measures, we provide tailored solutions for orphan disease research including: 

• Electronic Clinician Ratings 
• Rater Training & Qualification
• COA data analytics
• Central ratings and reviews 
• Scientific oversight

Click to read our brochure and learn how Signant is driving success in orphan disease research.